Jasper Therapeutics Inc. (JSPR)
JSPR trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4956
-10.70% on the day
Market cap
$16.5M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | JSPR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001788028 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-09-19 |
| Latest annual report AMENDMENT NO. 1 TO FORM 10-K | 10-K/A | 2026-04-30 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-07 |
| Latest proxy PROXY STATEMENT | PRE 14A | 2026-10-09 |
Source: SEC EDGAR submissions feed, 477 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DYAI | Dyadic International Inc. | $0.4253 | +1.00% | $17.0M |
| BCDA | BioCardia Inc. | $0.9903 | -2.91% | $15.0M |
| ATYR | aTyr Pharma Inc. | $0.2011 | -6.38% | $19.7M |
| TCRX | TScan Therapeutics Inc. | $0.2167 | -8.91% | $13.8M |
| ESLA | Estrella Immunopharma Inc. | $0.3140 | -4.44% | $13.7M |
| PLUR | Pluri Inc. | $0.9400 | -3.08% | $11.9M |
| PASG | Passage Bio Inc. | $3.64 | -20.00% | $11.7M |
| INAB | IN8bio Inc. | $1.18 | -4.07% | $11.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier